Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | ALDH2 | P05091 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP3 | P08254 | 1/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3628031 | 0.90 | POLB (0.41) | ALDH1A1ALDH2LMNAKDM4EHPGD | |
| SCHEMBL8633814 | 0.86 | LMNA (0.44) | ALDH1A1ALDH2LMNAHPGDGAA | |
| SCHEMBL28912905 | 0.85 | ALDH1A1 (0.46) | ALDH1A1ALDH2LMNAKDM4EHPGD | |
| SCHEMBL1396575 | 0.85 | ALDH1A1 (0.37) | ALDH1A1ALDH2LMNAKDM4EHPGD | |
| SCHEMBL13246032 | 0.84 | LMNA (0.43) | ALDH1A1ALDH2LMNAKDM4EHSD17B10 | |
| SCHEMBL8634142 | 0.83 | ALDH1A1 (0.48) | ALDH1A1ALDH2KDM4EHPGDL3MBTL1 | |
| SCHEMBL5465384 | 0.83 | LMNA (0.52) | ALDH1A1ALDH2LMNAKDM4EHPGD | |
| SCHEMBL10489425 | 0.82 | CA12 (0.48) | ALDH1A1ALDH2LMNAHPGDMMP1 | |
| SCHEMBL25163064 | 0.81 | LMNA (0.62) | ALDH1A1ALDH2LMNAHPGDL3MBTL1 | |
| SCHEMBL22271561 | 0.81 | ALDH1A1 (0.43) | ALDH1A1ALDH2LMNAKDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5851274-A | Ink jet ink compositions and processes for high resolution and high speed printing | XEROX CORPORATION (US) | 1998-12-22 | — | — | US | claimed |
| EP-0853107-A1 | Ink jet ink compositions comprising hydroxyamide derivatives and printing processes | XEROX CORPORATION (US) | 1998-07-15 | — | — | EP | claimed |
| EP-0853108-A1 | Ink jet ink compositions and processes for high resolution and high speed printing | XEROX CORPORATION (US) | 1998-07-15 | — | — | EP | claimed |
| US-5693129-A | AQUEOUS MIXCTURE CONTAINING COLORING AND A HYDROXYAMIDE, THIOAMIDE, MERCAPTOAMIDE, MERCAPTOTHIOAMIDE OR AN OXYALKYLENE OR A THIOALKYLENE REACTION PRODUCT OF THE AMIDES, FOR HIGH RESOLUTION, REDUCED CURLING | XEROX CORPORATION (US) | 1997-12-02 | — | — | US | claimed |
| CN-119841829-A | Compounds for the treatment of PI3K gamma mediated diseases and uses thereof | 中国科学院合肥物质科学研究院 | 2025-04-18 | — | — | CN | disclosed |
| US-8288540-B2 | 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors | IRM LLC (BM) | 2012-10-16 | — | — | US | disclosed |
| EP-2425831-A1 | SCCA-1 PRODUCTION INHIBITOR HAVING A CARBOXAMIDE DERIVATIVE AND/OR A SALT THEREOF AS AN ACTIVE INGREDIENT | Shiseido Co., Ltd. (JP) | 2012-03-07 | — | — | EP | disclosed |
| US-8002120-B2 | Modified polyamide membrane | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-08-23 | — | — | US | disclosed |
| US-20110120942-A1 | MODIFIED POLYAMIDE MEMBRANE | THE DOW CHEMICAL COMPANY | 2011-05-26 | — | — | US | disclosed |
| US-7905361-B2 | Polyamides modified with oxazoline, thiazoline compounds; overcoating with polyoxazoline or polyoxyethylene glycol; heating; reduced fouling, microbiocides, storage stability | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-03-15 | — | — | US | disclosed |
| US-20110053952-A1 | 2-HETEROARYLAMINO-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS | IRM LLC (BM) | 2011-03-03 | — | — | US | disclosed |
| US-7897601-B2 | Cannabinoid receptor modulators | INTERVET, INC. (US) | 2011-03-01 | — | — | US | disclosed |
| US-20080139559-A1 | DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS | IRM LLC, A DELAWARE LIMITED LIABILITY COMAPNY (BM) | 2008-06-12 | — | — | US | disclosed |
| US-20070197628-A1 | Cannabinoid receptor modulators | INTERVET INTERNATIONAL B.V. (NL) | 2007-08-23 | — | — | US | disclosed |
| US-20070149538-A1 | Diarylamine-Containing Compounds and Compositions, and their use as Modulators of C-Kit Receptors | IRM LLC (BM) | 2007-06-28 | — | — | US | disclosed |
| US-5851274-A | Ink jet ink compositions and processes for high resolution and high speed printing | XEROX CORPORATION (US) | 1998-12-22 | — | — | US | disclosed |
| EP-0853107-A1 | Ink jet ink compositions comprising hydroxyamide derivatives and printing processes | XEROX CORPORATION (US) | 1998-07-15 | — | — | EP | disclosed |
| EP-0853108-A1 | Ink jet ink compositions and processes for high resolution and high speed printing | XEROX CORPORATION (US) | 1998-07-15 | — | — | EP | disclosed |
| US-5693129-A | AQUEOUS MIXCTURE CONTAINING COLORING AND A HYDROXYAMIDE, THIOAMIDE, MERCAPTOAMIDE, MERCAPTOTHIOAMIDE OR AN OXYALKYLENE OR A THIOALKYLENE REACTION PRODUCT OF THE AMIDES, FOR HIGH RESOLUTION, REDUCED CURLING | XEROX CORPORATION (US) | 1997-12-02 | — | — | US | disclosed |
| US-4035190-A | 2-ISOXAZOLIN-3-HETEROCYCLIC-SUBSTITUTED | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1977-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070197628-A1 | Cannabinoid receptor modulators | CNR1, CNR2, GPR18 | ALDH1A1 1999/4885ALDH2 2218/4885LMNA 3635/4885 |
| US-20110053952-A1 | 2-HETEROARYLAMINO-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS | FYN, LCK, ERBB2 | ALDH1A1 3888/4885ALDH2 3842/4885LMNA 4877/4885 |
| US-20070149538-A1 | Diarylamine-Containing Compounds and Compositions, and their use as Modulators of C-Kit Receptors | KIT, PRKCH, PRKCE | ALDH1A1 1472/4885ALDH2 2076/4885LMNA 710/4885 |
| US-20080139559-A1 | DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS | KIT, PRKCH, PRKCE | ALDH1A1 1472/4885ALDH2 2076/4885LMNA 710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.